Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Device Closure Versus Medical Therapy for Secondary Prevention in Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale : DEFENSE-PFO

NCT01550588 is registered in ClinicalTrials.gov with Jae-Kwan Song as lead sponsor.

NCT NCT01550588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01550588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Device Closure Versus Medical Therapy for Secondary Prevention in Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale : DEFENSE-PFO
Lead sponsor
Jae-Kwan Song
Phase
Phase 4
Overall status
Unknown status
Start date
February 29, 2012
Completion date
February 29, 2020
Enrollment
210 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

patent foramen ovale